Previous reports have documented that, among its diverse mechanisms of activity, as a pan-HDAC inhibitor panobinostat transcriptionally perturbs large numbers of gene-expressions beyond what would be regulated by menin-MLL1 in AML cells, including repression of pro-growth and pro-survival gene-expressions [49]. This evidence concerns the gene HDAC9 and acute myeloid leukemia.